Year: 2017
Type: article
Abstract: Vascular cognitive impairment is spectrum of cognitive change related to vascular pathology from early cognitive decline to dementia. Management of risk factors that may increase damage to the brain vasculature is an important treatment strategy. There is substantial evidence that treating risk factors may improve outcomes and help delay further decline. Thus, pharmacological therapy primarily helps to prevent worsening of vascular dementia by controlling the underlying disease, such as hypertension, hyperlipidemia or diabetes mellitus. To date, there is no approved drug for vascular dementia, and the use of acetylcholinesterase inhibitors should not be routinely prescribed.
Source: Journal of Thai Stroke Society
Author: Permphan Dharmasaroja
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2898231135
